Yunfeng He Selected Research

Cyclin D1

8/2011	shRNA targeting PLCε inhibits bladder cancer cell growth in vitro and in vivo.
10/2008	Impaired delta NP63 expression is associated with poor tumor development in transitional cell carcinoma of the bladder.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yunfeng He Research Topics

Disease

17	Neoplasms (Cancer) 05/2022 - 10/2008
8	Urinary Bladder Neoplasms (Bladder Cancer) 05/2022 - 12/2009
3	Renal Cell Carcinoma (Grawitz Tumor) 01/2021 - 11/2015
2	Prostatic Neoplasms (Prostate Cancer) 01/2020 - 01/2019
2	Carcinoma (Carcinomatosis) 10/2017 - 10/2008
1	Cushing Syndrome 02/2020
1	Hyperaldosteronism (Conn Syndrome) 02/2020
1	Glioma (Gliomas) 01/2019
1	Adenoma (Adenomas) 01/2019
1	Adrenocortical Carcinoma 01/2019
1	Neoplasm Metastasis (Metastasis) 10/2017
1	Prostatic Hyperplasia (Benign Prostatic Hyperplasia) 01/2016
1	Tonsillitis 03/2014
1	Liver Neoplasms (Liver Cancer) 01/2014
1	Carcinogenesis 01/2013
1	Colonic Neoplasms (Colon Cancer) 01/2013
1	Osteosarcoma (Osteogenic Sarcoma) 01/2013
1	Chromosome Breakage 01/2013
1	Bone Fractures (Bone Fracture) 01/2013
1	Transitional Cell Carcinoma 10/2012
1	Fibrosis (Cirrhosis) 03/2011
1	Asthma (Bronchial Asthma) 10/2008
1	Inflammation (Inflammations) 10/2008

Drug/Important Bio-Agent (IBA)

6	Proteins (Proteins, Gene)FDA Link 01/2016 - 10/2008
3	Pharmaceutical PreparationsIBA 01/2019 - 10/2008
3	Messenger RNA (mRNA)IBA 10/2017 - 06/2010
3	CytokinesIBA 01/2017 - 10/2008
2	Circular RNAIBA 05/2022 - 10/2017
2	Competitive Endogenous RNAIBA 05/2022 - 10/2017
2	Biological ProductsIBA 01/2021 - 03/2010
2	Hydrocortisone (Cortisol)FDA LinkGeneric 02/2020 - 01/2019
2	AldosteroneIBA 02/2020 - 01/2019
2	Phospholipases (Phospholipase)IBA 05/2019 - 08/2011
2	DNA (Deoxyribonucleic Acid)IBA 01/2019 - 01/2013
2	Cell Adhesion MoleculesIBA 01/2017 - 03/2010
2	CateninsIBA 01/2013 - 01/2013
2	Small Interfering RNA (siRNA)IBA 08/2011 - 10/2008
2	Cyclin D1IBA 08/2011 - 10/2008
2	Caspase 3 (Caspase-3)IBA 06/2010 - 12/2009
1	Dexamethasone (Maxidex)FDA LinkGeneric 02/2020
1	Adrenocorticotropic Hormone (ACTH)FDA Link 02/2020
1	Androgen Receptors (Androgen Receptor)IBA 01/2020
1	L-Lactate Dehydrogenase (Lactate Dehydrogenase)IBA 05/2019
1	Steroid 11-beta-Hydroxylase (11 beta-Hydroxylase)IBA 01/2019
1	TankyrasesIBA 01/2019
1	Cytochrome P-450 CYP11B2 (CYP11B2)IBA 01/2019
1	Interleukin-6 (Interleukin 6)IBA 01/2017
1	lycium barbarum polysaccharideIBA 11/2015
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 02/2015
1	Explosive Agents (Explosives)IBA 03/2014
1	Biomarkers (Surrogate Marker)IBA 01/2014
1	Tumor Biomarkers (Tumor Markers)IBA 01/2014
1	Carcinoembryonic AntigenIBA 01/2014
1	Fetal Proteins (Fetoprotein)IBA 01/2014
1	AntigensIBA 01/2014
1	2- (2- amino- 3- methoxyphenyl)- 4H- 1- benzopyran- 4- oneIBA 01/2013
1	Formaldehyde poisoningIBA 01/2013
1	WortmanninIBA 01/2013
1	CalciumIBA 01/2013
1	Calcium-Binding ProteinsIBA 01/2013
1	S100 Proteins (S 100 Protein)IBA 01/2013
1	GenisteinIBA 01/2013
1	Histone Deacetylase InhibitorsIBA 01/2013
1	InterferonsIBA 10/2012
1	Methylnitrosourea (N-Methyl-N-nitrosourea)IBA 08/2012
1	Carbon Nanotubes (Carbon Nanotube)IBA 08/2012
1	Doxorubicin (Adriamycin)FDA LinkGeneric 08/2012
1	pirarubicinIBA 08/2012
1	Proliferating Cell Nuclear Antigen (PCNA)IBA 08/2011
1	Transforming Growth Factors (Transforming Growth Factor)IBA 03/2011
1	Antisense OligonucleotidesIBA 06/2010
1	Immunoglobulins (Immunoglobulin)IBA 03/2010
1	Ganciclovir (Cytovene)FDA LinkGeneric 12/2009
1	Saline SolutionIBA 12/2009
1	Interleukin-4 Receptors (Interleukin 4 Receptor)IBA 10/2008
1	Protein Isoforms (Isoforms)IBA 10/2008
1	Interleukin-4 (Interleukin 4)IBA 10/2008
1	Therapeutic UsesIBA 10/2008
1	Interleukin-13IBA 10/2008

Therapy/Procedure

4	Therapeutics 02/2020 - 06/2010
1	Drug Therapy (Chemotherapy) 08/2012
1	Intraperitoneal Injections 12/2009